The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story.
about
Potential approaches to improve the outcomes of donation after cardiac death liver graftsAetiology and risk factors of ischaemic cholangiopathy after liver transplantationDonation after cardio-circulatory death liver transplantationExtended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation.Donations After Circulatory Death in Liver Transplant.Superior survival using living donors and donor-recipient matching using a novel living donor risk index.Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center.Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry.Clinical outcomes and quality of life in recipients of livers donated after cardiac deathIschemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation.Donation after cardiac death: a 29-year experience.Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure.Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit.Endoscopic management of biliary complications following liver transplantation after donation from cardiac death donors.Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathyExpanded criteria donors.NUTORC-a transdisciplinary health services and outcomes research team in transplantationRadiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes.Increasing organ donation and transplantation: the U.S. experience over the past decade.The Scottish Liver Transplant Unit: current and future perspectives.Donation after cardiac death in abdominal organ transplantation.Increasing the donor pool: consideration of prehospital cardiac arrest in controlled donation after circulatory death for liver transplantation.Attitudes and barriers to the use of DCD livers: Comparison of a U.S. transplant center survey to the United Network for Organ Sharing data.Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids.Extended criteria donors in liver transplantation Part I: reviewing the impact of determining factors.Can we prevent ischemic-type biliary lesions in donation after circulatory determination of death liver transplantation?Management of biliary complications in the liver transplant patient.Dual chamber stent prevents organ malperfusion in a model of donation after cardiac deathTiming of hepatic artery reperfusion and biliary strictures in liver transplantation.The economic implications of broader sharing of liver allografts.Donation after cardiac death organs for patients with hepatitis C virus: are we rolling the dice, or are they just as good as any?Donation after cardiac death liver transplantation is associated with increased risk of end-stage renal disease.Current situation of donation after circulatory death in European countries.Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors.Comparison of liver transplantation outcomes from adult split liver and circulatory death donors.Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort.Liver Transplantation Using Grafts From Donors After Circulatory Death: A Propensity Score-Matched Study From a Single Center.Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy.A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation.
P2860
Q26745960-85F191F0-AD30-4994-81EB-C5A0F9F1D015Q28659287-A93C9A4A-7256-4273-9139-C144DA18277EQ28728002-311C2605-293C-4664-8BBB-F5379932974DQ30251928-EB324674-3190-4E77-8CB2-5706BAD2E62AQ33771943-DA9448BD-74C7-474F-A8AB-2C8711F17F32Q34415850-48403028-4F14-4B4E-8AB3-82AC325AD06DQ35010160-AB195CFD-3374-4CB2-B896-600FEA0AFF85Q35010230-077FE4DF-AE75-44D6-A289-A821BDEC141AQ35223888-F070ED57-48EE-401A-A394-DF30446B5557Q35422315-461F9E90-A2C8-4384-B630-6BC81BDA86E2Q35864132-A829135E-53AB-43EB-9784-6C47A653959DQ35975893-0801C1D5-6A02-443E-BCEA-E2B8EE8FF0DDQ35988322-B73B778B-1C26-4C91-BDAA-6F2FED89A03CQ36003299-694DF37E-D009-4FBA-AF77-F4C2ADA0612CQ36231832-67501F7A-80D6-4AE9-97D3-AEB8562FCEA6Q36724375-FCB6C63F-8A58-467E-81F8-941DBAC87393Q36733650-6B06A97D-2709-4E82-8C83-954056E9D5D2Q36825871-44BBF4E8-7BB1-4177-A963-E59CE7EB23FAQ36828129-BA11EE7A-8311-4FF9-A9FC-C31ED3690F44Q37826221-D8F609D1-A3D8-4E56-9696-F4B84E2A3ED2Q37956844-D48F830B-EA43-46DE-97FB-6AF30AB86CE9Q38017159-D5EB50C8-29A2-4181-A35B-75EE5B39467CQ38154246-EF942714-1473-4A9C-9AC5-7E6EB340D2D6Q38611740-203F95E1-9C71-4859-A12F-290DF2EB2ABBQ38696818-152B2E7C-C5D6-4746-836C-29441CCBB74FQ38720932-77F478BE-3B7A-43C1-96EC-7F559F6FF0FEQ38809207-29597B55-2DE9-4A0C-8F4B-C5E874356E55Q41103126-CFE6BED9-A9F4-4A92-B8FA-3D6EA412D704Q41657864-7568F693-319F-4EEA-99BA-0F8E7DA79828Q42178377-6D662825-2B10-491F-86AF-5E2401DE3CF0Q42694182-37CFE611-D152-4D65-8E55-877D605550A3Q43036082-D32FDAF0-0E93-4115-A544-0FEC9E6436A0Q45260326-61A6289B-9FE9-450E-BA89-900029C0C82EQ45947936-871CF0AB-C819-4CC0-85DF-D9BBA2BD606CQ46222675-F2788A67-1472-4BAB-A2FF-1E882319324BQ47569487-D2FD0FF8-DCFE-4025-BCE4-6B054F2321A3Q47597968-AE900305-83FB-44B2-8795-F442ECD6C3CBQ47924571-F966488B-AFF5-4614-912E-E6D2E7BF1650Q48271802-19E83D2F-5FC6-43E2-8537-A3FC933930C6Q48643260-B0E06E50-C663-4883-AA1D-62024F44542C
P2860
The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The impact of ischemic cholang ...... rdiac death: the untold story.
@en
The impact of ischemic cholang ...... rdiac death: the untold story.
@nl
type
label
The impact of ischemic cholang ...... rdiac death: the untold story.
@en
The impact of ischemic cholang ...... rdiac death: the untold story.
@nl
prefLabel
The impact of ischemic cholang ...... rdiac death: the untold story.
@en
The impact of ischemic cholang ...... rdiac death: the untold story.
@nl
P2093
P2860
P1433
P1476
The impact of ischemic cholang ...... rdiac death: the untold story.
@en
P2093
Anton I Skaro
Colleen L Jay
Edward Wang
John A Martin
Joseph M Feinglass
Luke B Preczewski
Michael M Abecassis
Sarina Pasricha
Talia B Baker
Vadim Lyuksemburg
P2860
P304
543-52; discussion 552-3
P356
10.1016/J.SURG.2009.06.052
P407
P577
2009-10-01T00:00:00Z